Clinical Trials Directory

Trials / Completed

CompletedNCT03065140

Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity

Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity - the MISTY Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Aberdeen · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Early research found that high levels of fat within muscle meant poorer control of blood sugar. However, more recent research has shown that athletes have similar levels of fat within muscle, but in contrast, they have very good control of blood sugar. The investigators are not sure why this is and want to find out if the fat within muscle can be changed to improve blood sugar control, as good blood sugar control reduces the risk of heart disease, diabetes and stroke.

Detailed description

Higher levels of triglycerides (TG) and diacylglycerols (DAG) are found in skeletal muscle of patients with obesity/diabetes as well as in trained athletes. Despite similar metabolic storage, patients and athletes have opposite insulin sensitivity phenotypes and an explanation for this is lacking. The investigators' objective is to understand how these fat compartments can be beneficially modulated to improve insulin resistance and cardio-metabolic risk. The investigators will investigate if either structural differences (saturated versus unsaturated balance of TG and DAG side-chains) or different handling abilities (fast versus slow lipid pool turnover) will be induced by exercise capacity interventions in athletes and in diabetic patients. In a longitudinal study pre- and post-exercise, the investigators will use novel, non-invasive 1H-Magnetic Resonance Spectroscopy to benchmark the saturated/unsaturated compartments against skeletal muscle biopsies for the first time and stable isotope analysis for fat compartments' rate of turnover.

Conditions

Interventions

TypeNameDescription
OTHERTraining or detrainingA period of detraining or a supervised exercise program.

Timeline

Start date
2016-09-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2017-02-27
Last updated
2022-08-31

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03065140. Inclusion in this directory is not an endorsement.